Difficulties in Treatment and Management of Epilepsy and Challenges in New Drug Development
Epilepsy is a serious neurological disorder that affects around 50 million people worldwide. Almost 30% of epileptic patients suffer from pharmacoresistance, which is associated with social isolation, dependent behaviour, low marriage rates, unemployment, psychological issues and reduced quality of...
Main Author: | Abdul Wahab |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/7/2090/ |
Similar Items
-
Antiepileptic Drug Discovery and Development: What Have We Learned and Where Are We Going?
by: Jeffrey L. Krajewski, et al.
Published: (2010-09-01) -
Diabetes Mellitus and Drug Refractory Epilepsy
by: J Gordon Millichap
Published: (1997-06-01) -
Evaluation of magnetic resonance imaging-negative drug-resistant epilepsy
by: Aashit K Shah, et al.
Published: (2014-01-01) -
Perampanel: New drug for treatment of refractory partial onset seizures
by: Santosh Kumar Singh, et al.
Published: (2014-01-01) -
Editorial: Burden of Illness in People With Epilepsy: From Population-Based Studies to Precision Medicine
by: Adam Strzelczyk, et al.
Published: (2019-01-01)